Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2018 16:15 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics Reports Third Quarter 2018 Financial Results

MINNEAPOLIS, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized...
November 14, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer. PITTSBURGH and LONDON, Nov. 14,...
November 08, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018

MINNEAPOLIS, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized...
November 07, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

MINNEAPOLIS, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized...
October 29, 2018 20:05 ET | Source: Precision Therapeutics Inc.

Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966

Precision Therapeutics Files Form S-4 Regarding Proposed Merger with Helomics Holding Corporation MINNEAPOLIS, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT)...
October 11, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

MINNEAPOLIS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized...
October 09, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World

MINNEAPOLIS, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the...
September 27, 2018 15:00 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics schließt ersten Verkauf seines STREAMWAY-Systems in Europa ab

MINNEAPOLIS, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) („Precision“ oder „das Unternehmen“) freut sich bekanntgeben zu können, dass es den ersten Verkauf des...
September 27, 2018 15:00 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics réalise la première vente du système STREAMWAY en Europe

MINNEAPOLIS, 27 sept. 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ : AIPT) (« Precision » ou « la Société ») est heureuse d'annoncer la réalisation de sa première vente européenne...
September 27, 2018 08:30 ET | Source: Precision Therapeutics Inc.

Precision Therapeutics Secures First STREAMWAY System Sale in Europe

MINNEAPOLIS, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”) is pleased to announce it has secured its first European sale of the...